诊断时吸烟状态在HPV相关口咽癌中的重要性
多变量分析显示,当前吸烟者OS劣于从不吸烟者(校正HR 2.37,95%CI 1.26-4.45,p<0.01)和既往吸烟者(校正HR 2.58,95%CI 1.40-4.73,p<0.01),PFS劣于从不吸烟者(校正HR 1.83,95%CI 1.00-3.35,p=0.04);吸烟状态未预测CSS。结论认为详细吸烟行为应纳入HPV相关口咽癌风险分组细化及未来试验设计。
要点
- 当前吸烟者OS显著劣于从不吸烟者(校正HR 2.37,p<0.01)和既往吸烟者(校正HR 2.58,p<0.01)。
- 当前吸烟者PFS劣于从不吸烟者(校正HR 1.83,95%CI 1.00-3.35,p=0.04)。
- 吸烟状态未预测癌症特异性生存(CSS)。
核心结论
- 诊断时详细吸烟行为应考虑用于细化接受放疗的HPV相关口咽癌风险分组,并影响未来试验的入组资格和分层设计。
主要发现
- 当前吸烟者OS劣于从不吸烟者(校正HR 2.37,95%CI 1.26-4.45,p<0.01)和既往吸烟者(校正HR 2.58,95%CI 1.40-4.73,p<0.01)。
- 当前吸烟者PFS劣于从不吸烟者(校正HR 1.83,95%CI 1.00-3.35,p=0.04)。
- 吸烟状态未预测癌症特异性生存(CSS)。
临床怎么用
- 在HPV相关口咽癌接受放化疗的患者中,应详细记录诊断时吸烟状态以辅助风险分层。
- 未来临床试验设计可考虑将吸烟状态纳入入组资格和分层因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Smoking status at point of diagnosis is not used in defining risk groups for human papillomavirus (HPV)-associated oropharyngeal cancer (OPC) despite its prognostic value in head and neck cancer. METHODS: Retrospective analysis of consecutive patients treated with chemoradiotherapy between January 2005 and July 2017 was performed with multivariable analysis to explore the impact of smoking status at diagnosis (current/former/never) on overall survival (OS), cancer-specific survival (CSS) and progression-free survival (PFS). RESULTS: Median follow-up was 61 months. Four hundred and four patients were included. Current smokers had inferior OS versus never and former smokers [adjusted HR 2.37 (95% CI 1.26-4.45, p < 0.01) and 2.58 (95% CI 1.40-4.73, p < 0.01), respectively] and inferior PFS versus never smokers [adjusted HR 1.83 (95% CI 1.00-3.35, p = 0.04)]. Smoking status did not predict for CSS. CONCLUSION: Detailed smoking behavior should be considered in refining risk groups in HPV-associated OPC treated with radiotherapy and in future trial design eligibility and stratification.
引用
- Liu HY, Daniels CP, Trada Y, et al. The importance of smoking status at diagnosis in human papillomavirus-associated oropharyngeal cancer. Head Neck. 2021. PMID: 33427358. doi:10.1002/hed.26612
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。